bpc 157 human studies randomized clinical trial BPC-157 – No Proof Required! | Office for Science and Society BPC-157 and Healing Peptides: Hype
Description
*This product and these statements have not been evaluated by the FDA
The treatment plan depends on clinical goals: sleep/anxiety, vasomotor symptoms, libido, bone health, and more
For people considering switching from tirzepatide to semaglutide or vice versa, the decision should be based on efficacy, tolerability, cost, and availability rather than on the B12 additive, since both compounds have B12-containing versions with the same potential concerns
Vitamin B12 deficiency can lead to the development of megaloblastic anemia, demyelination, and other types of neurological damage
